In today's world, we find ourselves struggling to fight one of the worst pandemics in the history of humanity known as COVID-2019 caused by a coronavirus. If we detect the virus at an early stage (before it enters the lower respiratory tract), the patient can be treated quickly. Once the virus reaches the lungs, we observe ground-glass opacity in the chest X-ray due to fibrosis in the lungs. Due to the significant differences between X-ray images of an infected and non-infected person, artificial intelligence techniques can be used to identify the presence and severity of the infection. We propose a classification model that can analyze the chest X-rays and help in the accurate diagnosis of COVID-19. Our methodology classifies the chest X-rays into 4 classes viz. normal, pneumonia, tuberculosis (TB), and COVID-19. Further, the X-rays indicating COVID-19 are classified on severity-basis into mild, medium, and severe. The deep learning model used for the classification of pneumonia, TB, and normal is VGG16 with an accuracy of 95.9 %. For the segregation of normal pneumonia and COVID-19, the DenseNet-161 was used with an accuracy of 98.9 %. ResNet-18 worked best for severity classification achieving accuracy up to 76 %. Our approach allows mass screening of the people using X-rays as a primary validation for COVID-19.
In today's world, we find ourselves struggling to fight one of the worst pandemics in the history of humanity known as COVID-2019 caused by a coronavirus. When the virus reaches the lungs, we observe ground-glass opacity in the chest X-ray due to fibrosis in the lungs. Due to the significant differences between X-ray images of an infected and non-infected person, artificial intelligence techniques can be used to identify the presence and severity of the infection. We propose a classification model that can analyze the chest X-rays and help in the accurate diagnosis of COVID-19. Our methodology classifies the chest X-rays into four classes viz. normal, pneumonia, tuberculosis (TB), and COVID-19. Further, the X-rays indicating COVID-19 are classified on a severity-basis into mild, medium, and severe. The deep learning model used for the classification of pneumonia, TB, and normal is VGG-16 with a test accuracy of 95.9 %. For the segregation of normal pneumonia and COVID-19, the DenseNet-161 was used with a test accuracy of 98.9 %, whereas the ResNet-18 worked best for severity classification achieving a test accuracy up to 76 %. Our approach allows mass screening of the people using X-rays as a primary validation for COVID-19.
Humanity today is suffering from one of the most dangerous pandemics in history, the Coronavirus Disease of 2019 (COVID-19). Although today there is immense advancement in the medical field with the latest technology, the COVID-19 pandemic has affected us severely. The virus is spreading rapidly, resulting in an escalation in the number of patients admitted. We propose a contextual patient classification system for better analysis of the data from the discharge summary available from the research hospital. The classification was done using the Knuth–Morris–Pratt algorithm. We have also analyzed the data of COVID-19 and non-COVID-19 patients. During the analysis, studies on the medicines, medical services and tests, pulse count, body temperature, and the overall effect of age and gender was done. The death versus survival ratio for the COVID-19 positive patients has also been studied. The classification accuracy of the contextual patient classification system achieved was 97.4%. The combination of data analysis and contextual patient classification will be helpful to all the sectors to be better prepared for any future waves of the COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.